Minimizing bleeding risks during gastric neuroendocrine tumor endoscopic submucosal dissection by pre-emptive EUS-guided epinephrine injection

Post written by Radhika Chavan, MD, DNB, FISG, FASGE, from Bharati Vidyapeeth, Katraj, India. A 38-year woman presented with upper GI bleeding. During evaluation, it was detected she had a large subepithelial lesion in the midbody of the stomach. Further evaluation with EUS revealed a large hypoechoic lesion confined to the submucosa with a large …

Continue reading Minimizing bleeding risks during gastric neuroendocrine tumor endoscopic submucosal dissection by pre-emptive EUS-guided epinephrine injection

EUS-guided glue injection for managing torrential bleeding during gastric neuroendocrine tumor endoscopic submucosal dissection: sealing the storm

Post written by Radhika Chavan, MD, DNB, from the Ansh Clinic, Ahmedabad, Gujarat, India. A 24-year man diagnosed with a type II gastric neuroendocrine tumor (NET) (size <20 mm) underwent endoscopic submucosal dissection (ESD) after multidisciplinary discussion. During distal extension of the initial incision, bleeding started and abruptly became profuse. Initial attempts to control the bleeding using …

Continue reading EUS-guided glue injection for managing torrential bleeding during gastric neuroendocrine tumor endoscopic submucosal dissection: sealing the storm

Use of inducible and limiting fluorescence in laparoscopic endoscopic cooperative surgery

Post written by Masaya Uesato, MD, PhD, Yoshihiro Kurata, MD, PhD, Yasunori Matsumoto, MD, PhD, Shunsuke Kainuma, MD, Takuya Hirosuna, MD, Ryota Otsuka, MD, PhD, Koichi Hayano, MD, PhD, and Hisahiro Matsubara, MD, PhD, from the Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan. We show you a case with a 6-mm-diameter …

Continue reading Use of inducible and limiting fluorescence in laparoscopic endoscopic cooperative surgery

Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: a propensity score–matching study

Post written by Hoonsub So, MD, from the Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea, Sung Woo Ko, MD, PhD, from the Department of Internal Medicine, Eunpyeong St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, and Do Hyun Park, MD, PhD, from the Department of …

Continue reading Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: a propensity score–matching study

Utilization of methylene blue–based submucosal injection to identify residual neuroendocrine tumor in the colon after endoscopic biopsy sampling

Post written by Weina Jing, MD, and Kai Deng, MD, from the Department of Gastroenterology & Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. This study provides a new way to find small residual neuroendocrine tumors. Submucosal staining assisted in the identification of minor lesions in the lamina propria of the mucosa. Neuroendocrine tumors of …

Continue reading Utilization of methylene blue–based submucosal injection to identify residual neuroendocrine tumor in the colon after endoscopic biopsy sampling

Impact of margin status on outcomes after endoscopic resection of well-differentiated duodenal neuroendocrine tumors

Post written by Shruti Mony, MD, from the Department of Gastroenterology, Johns Hopkins University, Baltimore, Maryland, USA. The focus of our study was to assess the recurrence patterns after endoscopic resection of nonampullary duodenal neuroendocrine tumors [DNETs]. Specifically, we wanted to identify the risk factors, effect of positive histologic margins, and optimal surveillance strategies including …

Continue reading Impact of margin status on outcomes after endoscopic resection of well-differentiated duodenal neuroendocrine tumors

EUS diagnosis of cystic pancreatic neuroendocrine tumors

Post written by Harry R. Aslanian, MD, from the Section of Digestive Disease, Yale New Haven Medical Center, School of Medicine, New Haven, Connecticut, USA. We present a series of cases highlighting the EUS features of cystic pancreatic neuroendocrine tumors. Pancreas neuroendocrine tumors are rare and are less commonly cystic. The recognition and targeting of wall …

Continue reading EUS diagnosis of cystic pancreatic neuroendocrine tumors